Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
Net Income
Adaptive Biotechnologies Corp
Net Income Peer Comparison
Competitive Net Income Analysis
Latest Figures & CAGR of Competitors
Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Net Income
-$215.1m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Net Income
$6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
|
Danaher Corp
NYSE:DHR
|
Net Income
$4.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
13%
|
CAGR 10-Years
5%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Net Income
$777.9m
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
Agilent Technologies Inc
NYSE:A
|
Net Income
$1.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
2%
|
CAGR 10-Years
5%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Net Income
$1.4B
|
CAGR 3-Years
64%
|
CAGR 5-Years
37%
|
CAGR 10-Years
20%
|
See Also
What is Adaptive Biotechnologies Corp's Net Income?
Net Income
-215.1m
USD
Based on the financial report for Mar 31, 2024, Adaptive Biotechnologies Corp's Net Income amounts to -215.1m USD.
What is Adaptive Biotechnologies Corp's Net Income growth rate?
Net Income CAGR 5Y
-33%
Over the last year, the Net Income growth was -10%. The average annual Net Income growth rates for Adaptive Biotechnologies Corp have been -11% over the past three years , -33% over the past five years .